期刊文献+

ICP法测定预灌封注射器中的可提取总钨量 被引量:3

Determination of Total Tungsten Extracted from Prefilled Syringes by ICP
原文传递
导出
摘要 建立电感耦合等离子体发射光谱仪(ICP)法测定预灌封注射器(PFS)中钨的提取量和迁移量的方法。分别对提取溶剂(4%乙酸溶液、水和0.5%氨水溶液)、提取部位(不锈钢针头、针头连接玻璃尖端和整支注射器)和提取条件(高压灭菌和超声)进行考察,确定提取溶剂为0.5%氨水溶液,对整支注射器进行灌装提取且121℃高压灭菌1 h时,钨提取效率最高。用pH 4.0和pH 7.0乙酸铵缓冲液作为介质模拟迁移试验,测定迁移溶液中的钨含量。本研究建立的方法简单易行且准确可靠,可作为PFS中钨总量的测定方法。 An inductively coupled plasma spectrometry (ICP) method was established for the determination of tungsten which was extracted and migrated from prefilled syringes (PFS). The extraction solvents (4% acetic acid solution, water and 0.5% ammonia solution), extraction sites (stainless steel needle, needle connected with the glass tip and the whole syringe) and extraction conditions (sterilized in the autoclave and ultrasound) were investigated respectively. The results showed the efficiency of tungsten extraction was the highest when extracted with 0.5% ammonia solution to fill the whole syringe and sterilized at the condition of 121℃ for 1 h. The tungsten contents in the migration solutions were determined with pH 4.0 and pH 7.0 ammonium acetate buffer as the media for migration test. The method was simple, feasible, accurate, reliable and suitable for the detection of tungsten in PFS.
作者 侯晴晴 张兵 朱涵超 张毅兰 HOU Qingqing;ZHANG Bing;ZHU Hanchao(China State Institute of Pharmaceutical Industry, Shanghai 201203;CFDA Research and Inspection Center of Pharmaceutical Packaging Materials, Shanghai 201203)
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2019年第4期441-444,共4页 Chinese Journal of Pharmaceuticals
关键词 预灌封注射器 ICP 提取 迁移 prefilled syringes tungsten ICP extraction migration
  • 相关文献

参考文献1

二级参考文献12

  • 1贾如宝.钨(W)对人体健康的双向影响[J].金属世界,1995(4):27-27. 被引量:4
  • 2国家食品药品监督管理局.化学注射剂与药用玻璃包装容器相容性研究指导原则(试行)[R].2015.
  • 3Morandotti A,Swift R.Nexa注射器-苛刻产品的最佳选择[J].医药包装,2015,38(2):38-42.
  • 4Sharma B, Bader F, Templeman T, et al. Technical investigations into the cause of the increase incidenece of antibody-mediated pure red cell aplasia associated with EPREXOR[J]. Eur J Hosp Pharm, 2004, (5): 86-91.
  • 5Caster J, Williams N, Bresnick M. Leachables found in parenteral drug products[J]. Am Pharm Rev, 2004, 7(2): 70, 72-75.
  • 6Markovic I. Chanllenges associated with extracable and/or leachable substance in therapeutic biologic protein products[J]. Am Pharm Rev, 2006, 9(5): 20, 22, 24-27.
  • 7Allain L, Wang Q. Impact of package leachables on stability of pharmaceutical products[J]. Am Pharm Rev, 2007, 10(4): 38-44.
  • 8国家食品药品监督管理总局.YBB00062004--2015预灌封注射器用硼硅玻璃针管[S].
  • 9Guideline on the specification limits for residues of metal catalysts or metal reagents[R]. London, 2008-02-21.
  • 10[美]丹尼斯·简克(Dennis Jenke).药品与包装材料的相容性-可提取物与浸出物相关安全性研究[M].李茂忠,主审.杨会英,马玉楠,等译.北京:化学工业出版社,2012.

共引文献5

同被引文献36

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部